A detailed history of Harbour Investments, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Harbour Investments, Inc. holds 12,895 shares of DXCM stock, worth $958,614. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,895
Previous 11,849 8.83%
Holding current value
$958,614
Previous $1.34 Million 35.67%
% of portfolio
0.03%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$64.0 - $116.06 $66,944 - $121,398
1,046 Added 8.83%
12,895 $864,000
Q2 2024

Jul 26, 2024

SELL
$110.31 - $140.45 $8,052 - $10,252
-73 Reduced 0.61%
11,849 $1.34 Million
Q1 2024

Jul 22, 2024

BUY
$114.22 - $140.1 $1.13 Million - $1.39 Million
9,927 Added 497.59%
11,922 $1.65 Million
Q4 2023

Feb 16, 2024

BUY
$75.49 - $124.16 $125,237 - $205,981
1,659 Added 493.75%
1,995 $247,000
Q3 2023

Nov 15, 2023

BUY
$86.06 - $137.93 $10,327 - $16,551
120 Added 55.56%
336 $31,000
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $6,298 - $7,334
56 Added 35.0%
216 $27,000
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $2,912 - $3,441
28 Added 21.21%
160 $18,000
Q4 2022

Feb 15, 2023

BUY
$84.98 - $122.67 $7,818 - $11,285
92 Added 230.0%
132 $14,000
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $2,651 - $5,182
39 Added 3900.0%
40 $3,000
Q4 2021

Feb 16, 2022

SELL
$129.87 - $162.82 $2,597 - $3,256
-20 Reduced 95.24%
1 $1,000
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $204,776 - $274,762
-1,919 Reduced 98.92%
21 $11,000
Q1 2021

Aug 17, 2021

BUY
$84.79 - $104.74 $128,117 - $158,262
1,511 Added 352.21%
1,940 $697,000
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $36,374 - $44,933
429 New
429 $154,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.7B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.